mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.009 |
0.8 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.8 |